The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2014

Filed:

Dec. 13, 2012
Applicant:

Deutsches Krebsforschungszentrum, Heidelberg, DE;

Inventors:

Nathalie Salome, Dossenheim, DE;

Christiane Dinsart, Ladenburg, DE;

Nadine Michel, Dossenheim, DE;

Jean Rommelaere, Heidelberg, DE;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/23 (2006.01); A61K 39/235 (2006.01); C12N 7/00 (2006.01); A61K 35/76 (2006.01); C12N 15/86 (2006.01); C07K 14/005 (2006.01); C07K 16/08 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 35/768 (2013.01); C12N 2750/14332 (2013.01); C12N 2750/14343 (2013.01); C12N 15/86 (2013.01); C12N 2750/14322 (2013.01); C07K 14/005 (2013.01); C07K 16/081 (2013.01);
Abstract

Described are parvovirus variants derived, e.g., from H-1PV, showing higher anti-tumor potential compared to the wild type parvovirus, wherein said variant is characterized by (a) an amino acid substitution, alteration or addition, preferably substitution at position Lys96 of NS-2 and/or position Leu103 of NS-2 (together with a amino acid substitution at position Tyr595 of NS-1 in the latter case), or (b) an in-frame deletion in the parvovirus genome, preferably a deletion resulting in a large amino acid deletion in both the central part (aa 96-133) of NS-2 and the C-terminal part (aa 587-624) of NS-1. The present invention also relates to the use of said parvovirus variants for cancer therapy.


Find Patent Forward Citations

Salome, Nathalie. (2014). Modified parvovirus having enhanced anti-tumor efficacy (U.S. Patent No. 8916176). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8916176

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…